Patents by Inventor Ludwig H. Schlager

Ludwig H. Schlager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5017586
    Abstract: Derivatives of 5-aminomethyl-2-furanomethanol represented by formula (I), or pharmaceutically acceptable salts thereof, which possess calcium-antagonistic activity and are effective in lowering blood pressure, and a process for preparing and using the same: ##STR1## wherein R, R.sub.1, R.sub.2 and R.sub.2 ' each represent a lower alkyl group containing 1 to 4 carbon atoms, with the proviso that R.sub.2 and R.sub.2 ', together with N, may form a 5- or 6-membered saturated heterocyclic ring which may contain an additional heteroatom, selected from the group consisting of as O, N and S, or R.sub.2 ' represents an aralkyl group;wherein R.sub.3 and R.sub.4 are each selected from the group consisting of a hydrogen atom, a halogen, a nitro group and a methoxy group; andwherein R.sub.5 is selected from the group consisting of a halogen, a difluoromethoxy group, a trifluoromethyl group, a nitro group, a carbamylmethoxy group, a cyanomethoxy group and a mesyloxy group.
    Type: Grant
    Filed: May 12, 1989
    Date of Patent: May 21, 1991
    Assignee: Gerot-Pharmazeutika Gesellschaft m.b.H.
    Inventor: Ludwig H. Schlager
  • Patent number: 4913901
    Abstract: An orally administrable and stable solution containing as an active ingredient Methoxasalen (8-methoxyfuro-[3',-2':6,7]-coumarin) of the formula ##STR1## useful in the photochemotherapy of psoriasis, to a process for the preparation thereof and to a process for the use thereof.
    Type: Grant
    Filed: March 28, 1984
    Date of Patent: April 3, 1990
    Inventor: Ludwig H. Schlager
  • Patent number: 4795750
    Abstract: Quinazoline compounds of the general formula (I): ##STR1## in which (a) R is a hydrogen atom and R.sub.1 is an -(2-pyrrolidinon-1-yl)-alkyl group,(b) R is a methyl group and R.sub.1 is an -(mono- or dialkoxyphenyl)-alkyl group, p0 (c) R together with R.sub.1 forms a piperidine ring substituted with 2-keto-1-benzimidazolinyl radical in the 4-position of the piperidine group ring; or(d) R together with R.sub.1 forms a piperazine ring substituted with a hydroxyacyl group in the 4-position of the piperazine ring.
    Type: Grant
    Filed: December 4, 1986
    Date of Patent: January 3, 1989
    Assignee: Gerot-Pharmazeutika Gesellschaft
    Inventor: Ludwig H. Schlager
  • Patent number: 4388313
    Abstract: The disclosure is directed to new 3-hydroxy-1,4-benzodiazepine-2-ones and to the process for the preparation thereof. The compounds of the invention have the structural formula ##STR1## in which R is methoxy or nitrile, R.sub.1 is hydrogen, halogen, trifluoromethyl or nitro and R.sub.2 is hydrogen or halogen, with the proviso that R is different from methoxy, if R.sub.2 is o-halogen. The compounds have marked sedative and sleep prolonging activity when evaluated in standard pharmacological procedures.
    Type: Grant
    Filed: May 11, 1981
    Date of Patent: June 14, 1983
    Assignee: Gerot-Pharmazeutika Gesellschaft m.b.H.
    Inventor: Ludwig H. Schlager
  • Patent number: 4261987
    Abstract: Novel 3-Di-n-Propyl-Acetoxy-Benzodiazepine-2-Ones and use thereof as anti-convulsant compounds.
    Type: Grant
    Filed: December 14, 1978
    Date of Patent: April 14, 1981
    Assignee: Gerot Pharmazeutika Gesellschaft m.b.H.
    Inventor: Ludwig H. Schlager
  • Patent number: 3996278
    Abstract: 2-AMINOMETHYL-4,6-DIHALOGENPHENOL DERIVATIVES AND SALTS THEREOF WITH PHYSIOLOGICALLY ACCEPTABLE ACIDS OR BASES HAVING THE FORMULA: ##STR1## wherein X is the same halogen in both positions, R.sub.1 is a hydrogen atom or a lower alkyl group, R.sub.2 is an alkyl, cycloalkyl, aryl or aralkyl group, or R.sub.1 and R.sub.2 together with the nitrogen atom may form a saturated heterocyclic ring, which ring may be interrupted by an oxygen, nitrogen or sulfur atom, R.sub.3 is a hydrogen atom, an alkyl, alkoxyalkyl, carboxyalkyl, carbamylalkyl, aralkyl, acyl or sulfonyl group or a base radical, e.g. an alkali metal atom, and R.sub.3 " is a cyanoalkyl, hydroxyalkyl, carbalkoxy-alkyl, N,N-dialkylcarbamyl, N-alkylcarbamyl-alkyl or N,N-dialkylcarbamylalkyl group, are useful as diuretics and saluretics; some derivatives possess secretolytic activity.
    Type: Grant
    Filed: January 2, 1974
    Date of Patent: December 7, 1976
    Assignee: Gerot-Pharmazeutika Dr. Walter Otto K.G.
    Inventor: Ludwig H. Schlager
  • Patent number: 3996279
    Abstract: 2-AMINOMETHYL-4,6-DIHALOGENPHENOL DERIVATIVES AND SALTS THEREOF WITH PHYSIOLOGICALLY ACCEPTABLE ACIDS OR BASES HAVING THE FORMULA: ##STR1## wherein X is the same halogen in both positions, R.sub.1 is a hydrogen atom or a lower alkyl group, R.sub.2 is an alkyl, cycloalkyl, aryl or aralkyl group, or R.sub.1 and R.sub.2 together with the nitrogen atom may form a saturated heterocyclic ring, which ring may be interrupted by an oxygen, nitrogen or sulfur atom, R.sub.3 is a hydrogen atom, an alkyl, alkoxyalkyl, carboxyalkyl, carbamylalkyl, aralkyl, acyl or sulfonyl group or a base radical, e.g. an alkali metal atom, and R.sub.3 " is a cyanoalkyl, hydroxyalkyl, carbalkoxy-alkyl, N,N-dialkylcarbamyl, N-alkylcarbamyl-alkyl or N,N-dialkylcarbamylalkyl group, are useful as diuretics and saluretics; some derivatives possess secretolytic activity.
    Type: Grant
    Filed: October 31, 1974
    Date of Patent: December 7, 1976
    Assignee: Gerot-Pharmazeutika Dr. Walter Otto K.G.
    Inventor: Ludwig H. Schlager